2016. WFH World Congress – Improvement in Health Status and Quality of Life in Patients with Haemophilia B Treated with Nonacog Beta Pegol, an Extended Half-Life Glycopegylated Recombinant FIX Product

Kearny S, Meunier J, Hoxer CS, Yee DL. Improvement in Health Status and Quality of Life in Patients with Haemophilia B Treated with Nonacog Beta Pegol, an Extended Half-Life Glycopegylated Recombinant FIX Product. Haemophilia. 2016;22(Suppl. 4):119. Presented at: WFH 2016 World Congress; July 24-28, 2016; Orlando, FL, USA.